Disc Medicine announced it received a Commissioner's National Priority Voucher from the US FDA for bitopertin in erythropoietic protoporphyria and submitted a New Drug Application seeking accelerated ...
Disc Medicine Inc. CEO John Quisel said that top-line phase II findings from the study called Aurora with bitopertin in erythropoietic protoporphyria are “hard for us to interpret. This package of ...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the first patient implant in a U.S. Food ...
The U.S. FDA named the first nine recipients of the recently unveiled commissioner’s national priority voucher (CNPV) program ...
Disc Medicine, Inc. announced its plans for 2025, highlighting key developments in its clinical programs focused on hematologic diseases. The company will discuss plans for NDA submission of ...
WAYLAND, Mass. & WATERTOWN, Mass.--(BUSINESS WIRE)--Gemini Therapeutics, Inc. (Nasdaq: GMTX) (“Gemini”) and Disc Medicine, Inc. (“Disc”), a privately-held ...
MILWAUKEE, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), a global leader in power transmission technology for marine and land-based applications, announced today the successful ...
BRADFORD, Maine (WABI) - Just over the Hudson town line, in Bradford, a disc golf enthusiast has a new course open. It’s called circle two disc golf. Its purpose, and its name, is all about a love for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback